세계의 장기 이식 시장 - 산업 규모, 점유율, 동향, 기회, 예측, 제품별, 용도별, 이식 유형별, 최종 사용자별, 지역별, 경쟁(2020-2030년)
Organ Transplant Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By Type of Transplant, By End User, By Region and Competition, 2020-2030F
상품코드:1785218
리서치사:TechSci Research
발행일:2025년 08월
페이지 정보:영문 180 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계 장기 이식 시장은 2024년에 145억 6,000만 달러로 평가되었으며, 2030년까지 연평균 복합 성장률(CAGR) 8.93%로 예측 기간 동안 눈부신 성장을 이룰 것으로 예측되고 있습니다.
장기 이식 시장은 주로 장기 이식 절차를 다룹니다. 장기 이식은 장기 부전을 다루기 위해 공극을 채우거나 손상된 장기와 누락된 장기를 대체하기 위해 한 신체에서 장기를 제거하고 다른 신체에 이식하는 의료 개입입니다. 이 수술은 폐, 신장, 간과 같은 중요한 장기의 장기 부전을 치료하기 위해 수행되는 것이 일반적입니다. 장기 이식의 대상으로 가장 많이 고려되는 것은 뇌사 상태에있는 동안 다른 사람의 생명을 구할 수있는 건강한 장기를 가지고있는 사람입니다. 이 복잡한 절차를 수행하기 전에 환자와 그 가족의 동의를 얻는 것이 가장 중요합니다. 동의 없는 장기적출은 불법으로 비난되어야 할 행위로 간주되기 때문입니다. 예를 들어, 2024년 2월 현재 미국 보건자원 및 서비스국은 남성, 여성, 어린이 등 약 103,223명이 미국 내 장기 이식 대기자 목록에 등록되어 있다고 보고했습니다. 주요 국가에서 이러한 이식 수술에 대한 높은 수요는 예측 기간 동안 시장 성장을 크게 촉진할 것으로 예측됩니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
145억 6,000만 달러
시장 규모 : 2030년
241억 3,000만 달러
CAGR 2025-2030년
8.93%
급성장 부문
면역억제제
최대 시장
북미
시장 성장 촉진요인
장기부전과 장기제공 절차 증가
주요 시장 과제
이식 거부 반응
주요 시장 동향
기술과 개발의 진보
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 목소리
제5장 세계의 장기 이식 시장 전망
시장 규모와 예측
금액별
시장 점유율 및 예측
제품별(조직 제품, 장기 보존 제품, 이식 진단, 면역 억제제, 기타)
용도별(장기 이식, 조직 이식)
이식 유형별(자가 이식, 동종 이식, 기타)
최종 사용자별(병원, 이식 센터, 기타)
지역별
기업별(2024년)
시장 맵
제6장 북미의 장기 이식 시장 전망
시장 규모와 예측
시장 점유율 및 예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 장기 이식 시장 전망
시장 규모와 예측
시장 점유율 및 예측
유럽 : 국가별 분석
독일
영국
이탈리아
프랑스
스페인
제8장 아시아태평양의 장기 이식 시장 전망
시장 규모와 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 남미의 장기 이식 시장 전망
시장 규모와 예측
시장 점유율 및 예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 장기 이식 시장 전망
시장 규모와 예측
시장 점유율 및 예측
중동 및 아프리카 : 국가별 분석
남아프리카
사우디아라비아
아랍에미리트(UAE)
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
합병과 인수
제품 출시
최근 동향
제13장 Porter's Five Forces 분석
업계 내 경쟁
신규 진입의 가능성
공급자의 힘
고객의 힘
대체품의 위협
제14장 경쟁 구도
Abbvie, Inc.
Arthrex, Inc.
Zimmer Biomet
Medtronic plc
Novartis AG
Stryker Corporation
21st Century Medicine
BiolifeSolutions, Inc.
Teva Pharmaceuticals Industries Ltd.
Veloxis Pharmaceutical Inc.
제15장 전략적 제안
제16장 기업 소개와 면책사항
SHW
영문 목차
영문목차
Global Organ Transplant Market was valued at USD 14.56 Billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 8.93% through 2030F. The organ transplantation market primarily deals with the procedure of transplanting organs. Organ transplantation is a medical intervention wherein an organ is extracted from one body and implanted into another to address organ failure, fill a void, or replace a damaged or missing organ. This procedure is commonly employed to treat organ failure in vital organs such as the lungs, kidneys, liver, and others. Candidates most commonly considered for organ transplantation are individuals with brain death yet possessing healthy organs that can potentially save another person's life. Prior to undertaking this intricate procedure, obtaining the consent of the patient or their family is of utmost importance, as organ harvesting without consent is deemed an illegal and reprehensible act. For instace, as of February 2024, the Health Resources & Services Administration reported approximately 103,223 individuals including men, women, and children on the U.S. national organ transplant waiting list. This high demand for transplant procedures in major countries is expected to significantly drive market growth during the forecast period.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 14.56 Billion
Market Size 2030
USD 24.13 Billion
CAGR 2025-2030
8.93%
Fastest Growing Segment
Immunosuppressant Drugs
Largest Market
North America
Key Market Drivers
Growing Organ Failures and Organ Donations Procedure
The demand for organ transplantation has been on the rise globally in the past decade. This can be attributed to the increased prevalence of vital organ failure, higher success rates of transplantation, and improved post-transplant outcomes. The incidence of organ failure has also increased due to factors such as alcohol consumption, substance abuse, and unhealthy diets leading to chronic diseases affecting vital organs like lungs, kidneys, and liver. Organ transplantations have become a life-saving measure for patients, which is driving the growth of the transplantation market. The technological advancements in transplantation methods are contributing to the overall market revenue growth. The increasing prevalence of chronic diseases leading to organ failures is a significant driver for market growth. The global rise in organ donation has also influenced people to opt for organ transplantation, thereby accelerating market expansion. The the excessive consumption of alcohol and unhealthy dietary habits among the population contribute to organ failure, further augmenting market growth. The proliferation of personal insurance, coupled with lifestyle factors contributing to the burden of illness, is projected to bolster market growth. The procurement and preservation of organs and tissues are expected to provide further impetus to market expansion. In March 2023, the Pan American Health Organization (PAHO) and Spain's Ministry of Health signed an agreement aimed at strengthening the organ donation and transplantation sector in the United States. This collaboration seeks to enhance healthcare systems, share best practices, and promote policies that increase organ availability, ultimately addressing the growing demand for transplants across the country. This strategic partnership highlights the importance of international cooperation in overcoming organ shortages and improving transplant outcomes.
Key Market Challenges
Transplant Rejection
Transplant rejection is a complex process whereby the recipient's immune system mounts an attack against the transplanted organ or tissue, recognizing it as foreign. Three types of rejections are commonly observed: hyper-acute rejection, acute rejection, and chronic rejection. Despite meticulous donor matching, tissue typing, and the use of immunosuppressive medications, instances of transplant rejection still occur, leading to organ failure. Non-compliance with immunosuppressive drugs remains a significant contributing factor to rejection. Complications that may arise from transplant rejection include certain types of cancers, infections, impaired function of the transplanted tissue or organ, and adverse effects due to incorrect medication dosages. According to the Organ Procurement and Transplantation Network, approximately 4% of deceased donor kidney transplants experience failure within one year, while living donor kidney transplant recipients face a 14% failure rate at five years post-transplant. Consequently, these factors pose challenges to the growth of the market.
Key Market Trends
Advances In the Technology and Development
Advances in technology and development have the potential to significantly boost the demand for organ transplants in the future by addressing some of the challenges and limitations currently faced by the field. Progress in technology and advancements in the medical field have facilitated the transplantation of vital organs like the heart, kidney, liver, lungs, and various other organs. Key technical achievements encompass the development of vascular anastomosis techniques, effective management of the immune response through chemical immunosuppressants, and the formulation of preservation solutions. For instance, in June 2023, 3D BioFibR introduced μCollaFibR, a bio-ink additive, and CollaFibR 3D scaffold, an advanced collagen fiber product designed for bioprinting tissue and organ models. These innovations aim to enhance the precision and functionality of bioprinted structures, supporting the development of next-generation solutions in regenerative medicine and transplantation.
These advancements can improve organ availability, enhance transplant success rates, and expand the possibilities for transplantation. Technology has the potential to improve organ preservation and transportation methods, enabling organs to remain viable for longer periods before transplantation. This can lead to more efficient organ allocation, reduced wastage, and broader access to viable organs. Advances in bioprinting and tissue engineering are enabling the creation of bioengineered organs and tissues in the laboratory. This technology has the potential to address organ shortages by producing organs on demand, reducing the dependency on donor organs. Developments in immunosuppressive medications can lead to more targeted and effective treatments that minimize the risk of organ rejection. Improved immunosuppressive protocols can increase the success rate of transplant surgeries and reduce the need for high doses of medication. Research into xenotransplantation, the transplantation of organs from animals to humans, holds the potential to overcome the shortage of human donor organs. Advances in genetic editing and immunomodulation are making xenotransplantation more feasible and safer.
Key Market Players
Abbvie, Inc.
Arthrex, Inc.
Zimmer Biomet
Medtronic plc
Novartis AG
Stryker Corporation
21st Century Medicine
BiolifeSolutions, Inc.
Teva Pharmaceuticals Industries Ltd.
Veloxis Pharmaceutical Inc.
Report Scope:
In this report, the Global Organ Transplant Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Organ Transplant Market, By Product:
Tissue Products
Organ Preservation Products
Transplant Diagnostics
Immunosuppressant Drugs
Others
Organ Transplant Market, By Application:
Organ Transplantation
Tissue Transplantation
Organ Transplant Market, By Type of Transplant:
Autograft
Allograft
Others
Organ Transplant Market, By End User:
Hospitals
Transplant Centers
Others
Organ Transplant Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Organ Transplant Market.
Available Customizations:
Global Organ Transplant market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Organ Transplant Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Tissue Products, Organ Preservation Products, Transplant Diagnostics, Immunosuppressant Drugs, Others)
5.2.2. By Application (Organ Transplantation, Tissue Transplantation)
5.2.3. By Type of Transplant (Autograft, Allograft, Others)
5.2.4. By End User (Hospitals, Transplant Centers, Others)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. North America Organ Transplant Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
6.2.2. By Application
6.2.3. By Type of Transplant
6.2.4. By End User
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Organ Transplant Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Application
6.3.1.2.3. By Type of Transplant
6.3.1.2.4. By End User
6.3.2. Canada Organ Transplant Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Application
6.3.2.2.3. By Type of Transplant
6.3.2.2.4. By End User
6.3.3. Mexico Organ Transplant Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Application
6.3.3.2.3. By Type of Transplant
6.3.3.2.4. By End User
7. Europe Organ Transplant Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product
7.2.2. By Application
7.2.3. By Type of Transplant
7.2.4. By End User
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Organ Transplant Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Application
7.3.1.2.3. By Type of Transplant
7.3.1.2.4. By End User
7.3.2. United Kingdom Organ Transplant Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Application
7.3.2.2.3. By Type of Transplant
7.3.2.2.4. By End User
7.3.3. Italy Organ Transplant Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Application
7.3.3.2.3. By Type of Transplant
7.3.3.2.4. By End User
7.3.4. France Organ Transplant Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Application
7.3.4.2.3. By Type of Transplant
7.3.4.2.4. By End User
7.3.5. Spain Organ Transplant Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Application
7.3.5.2.3. By Type of Transplant
7.3.5.2.4. By End User
8. Asia-Pacific Organ Transplant Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product
8.2.2. By Application
8.2.3. By Type of Transplant
8.2.4. By End User
8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Organ Transplant Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Application
8.3.1.2.3. By Type of Transplant
8.3.1.2.4. By End User
8.3.2. India Organ Transplant Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Application
8.3.2.2.3. By Type of Transplant
8.3.2.2.4. By End User
8.3.3. Japan Organ Transplant Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Application
8.3.3.2.3. By Type of Transplant
8.3.3.2.4. By End User
8.3.4. South Korea Organ Transplant Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Application
8.3.4.2.3. By Type of Transplant
8.3.4.2.4. By End User
8.3.5. Australia Organ Transplant Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Application
8.3.5.2.3. By Type of Transplant
8.3.5.2.4. By End User
9. South America Organ Transplant Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product
9.2.2. By Application
9.2.3. By Type of Transplant
9.2.4. By End User
9.2.5. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Organ Transplant Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Application
9.3.1.2.3. By Type of Transplant
9.3.1.2.4. By End User
9.3.2. Argentina Organ Transplant Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Application
9.3.2.2.3. By Type of Transplant
9.3.2.2.4. By End User
9.3.3. Colombia Organ Transplant Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Application
9.3.3.2.3. By Type of Transplant
9.3.3.2.4. By End User
10. Middle East and Africa Organ Transplant Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product
10.2.2. By Application
10.2.3. By Type of Transplant
10.2.4. By End User
10.2.5. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Organ Transplant Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Application
10.3.1.2.3. By Type of Transplant
10.3.1.2.4. By End User
10.3.2. Saudi Arabia Organ Transplant Market Outlook
